Amprenavir Completed Phase N/A Trials for Human Immunodeficiency Virus (HIV) Infections Prevention

IndicationsStatusPurposePhase
CompletedPreventionNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT00002417A Study of Amprenavir in Patients With Protease Inhibitor-Related Complications